Hem › Ulcerös kolit
Kliniska studier för Ulcerös kolit som rekryterar i USA
80 studier för Ulcerös kolit rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- New York City, NY24 studier
- Orlando, FL23 studier
- Miami, FL22 studier
- Houston, TX18 studier
- San Antonio, TX16 studier
- Tacoma, WA15 studier
- Chicago, IL15 studier
- San Diego, CA15 studier
- Colorado Springs, CO14 studier
- St. Louis, MO14 studier
- Tyler, TX14 studier
- Los Angeles, CA13 studier
- Boston, MA12 studier
- Washington, DC12 studier
- Durham, NC11 studier
- Providence, RI11 studier
- Cincinnati, OH11 studier
- Louisville, KY10 studier
- Tampa, FL10 studier
- Parma, OH10 studier
- Lewisville, TX10 studier
- Atlanta, GA9 studier
- Evanston, IL9 studier
- Lubbock, TX9 studier
- Seattle, WA8 studier
- Round Rock, TX8 studier
- Scottsdale, AZ8 studier
- Lancaster, CA8 studier
- Dallas, TX8 studier
- Mountain View, CA8 studier
- Cleveland, OH8 studier
- Baltimore, MD8 studier
- Memphis, TN8 studier
- Metairie, LA8 studier
- Garland, TX8 studier
- Waukegan, IL7 studier
- Charlotte, NC7 studier
- Pittsburgh, PA7 studier
- Wyoming, MI7 studier
- Fort Worth, TX7 studier
Efter delstat
- Alabama7 studier
- Arizona19 studier
- Arkansas4 studier
- Colorado17 studier
- Connecticut11 studier
- District of Columbia3 studier
- Florida32 studier
- Georgia15 studier
- Idaho4 studier
- Illinois24 studier
- Indiana9 studier
- Iowa3 studier
- Kalifornien40 studier
- Kansas10 studier
- Kentucky13 studier
- Louisiana15 studier
- Maryland13 studier
- Massachusetts17 studier
- Michigan17 studier
- Minnesota8 studier
- Mississippi6 studier
- Missouri17 studier
- Nevada6 studier
- New Hampshire5 studier
- New Jersey7 studier
- New York31 studier
- North Carolina24 studier
- Ohio26 studier
- Oklahoma4 studier
- Oregon5 studier
- Pennsylvania13 studier
- Rhode Island11 studier
- South Carolina12 studier
- South Dakota4 studier
- Tennessee12 studier
- Texas34 studier
- Utah8 studier
- Virginia14 studier
- Washington22 studier
- Wisconsin4 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07697456Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RekryterarObservationsstudie
Ålder 18 till 85 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07619547A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
RekryterarFas 2
Ålder 16 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07296315A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RekryterarFas 1/2Friska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07845487Immune Regulation in Ulcerative Colitis or Crohn s Disease
RekryterarObservationsstudieFriska volontärer välkomna
1 Day – 75 Years · Alla kön · Uppdaterad 28 sep. 2026 · NCT00001184A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RekryterarFas 3
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RekryterarFas 2/3
Ålder 2 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RekryterarFas 3
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07513181A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07185009Microbiome-targeted Diet Therapy in Ulcerative Colitis
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT07520461Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.